Organs of the Immune System: Lymph Nodes

Among the organs that contribute to our immune response, there are two categories: primary lymphoid organs and secondary lymphoid organs.

Lymph nodes are considered secondary lymphoid organs, along with the spleen. Shaped like beans, they contain lymphocytes, macrophages and dendritic cells. Lymphocytes carrying antigen drain through the lymph nodes, leaving the antigen behind to be dealt with in the node.

Popular thinking very strongly associates lymph nodes with lymphoma, chiefly because one of the first symptoms of lymphoma is an enlarged lymph node, but this is a little misleading. A lymphocyte within the node can become cancerous, or a cancerous lymphocyte can arrive at the node from elsewhere in the body and remain there. But it is not necessary to have lymph node involvement in order to have lymphoma.

The Job of the Lymph Nodes

Lymph nodes cluster together at junctions of the lymphatic vessels of the lymph system. They filter harmful substances and other debris from the body that are collected from the tissues of the body outside of the bloodstream.

The lymphocytes, macrophages and dendritic cells in lymph nodes act as immune cells to kill the harmful substances brought there by the lymph vessels. Because lymph vessels run throughout the entire body, they drain back through lymph node clusters no matter where they are. The fluid in the vessels comes from the fingers and toes and goes all the way up to the scalp. This massive circulatory system is constantly working to clear these substances from the body's tissues before re-circulating again, always stopping at the lymph nodes to deposit what it collects so that the nodes can eliminate them from the body.

Familiar Lymph Node Clusters

Places where lymph nodes can be felt with one's fingers include:

  • Armpit
  • Groin
  • Under the jaw/chin
  • Behind the ears
  • Back of the head
  • Front, back and sides of the neck

Lymph Nodes in Lymphoma

Other cancers often involve the lymph nodes (when cells from tumors break away and reach the lymph nodes), but when cancers involve the B-cell lymphocytes or the T-cell lymphocytes, they are classified as lymphomas.

Lymph Node Removal

In order for a case of lymphoma to be diagnosed, a lymph node must be excised in a biopsy. This generally requires the removal of a single node. Since our bodies have several hundred lymph nodes, the loss of a single node isn't going to cause a problem.

However, when many nodes from the same cluster are removed, called either "dissection" or "lymph node sampling," this can create a big problem because lymph vessels arriving there no longer have a place to drain. Fluid back-up can occur, leading to what's called lymphedema.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap